Home Cart 0 Sign in  

[ CAS No. 69-74-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 69-74-9
Chemical Structure| 69-74-9
Structure of 69-74-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 69-74-9 ]

Related Doc. of [ 69-74-9 ]

Alternatived Products of [ 69-74-9 ]

Product Details of [ 69-74-9 ]

CAS No. :69-74-9 MDL No. :
Formula : C9H14ClN3O5 Boiling Point : -
Linear Structure Formula :- InChI Key :-
M.W : 279.68 Pubchem ID :-
Synonyms :
Cytosine β-D-arabinofuranoside hydrochloride;Cytosine Arabinoside hydrochloride;Ara-C hydrochloride

Calculated chemistry of [ 69-74-9 ]

Physicochemical Properties

Num. heavy atoms : 18
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.56
Num. rotatable bonds : 2
Num. H-bond acceptors : 6.0
Num. H-bond donors : 4.0
Molar Refractivity : 62.81
TPSA : 130.83 Ų

Pharmacokinetics

GI absorption : Low
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -8.95 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.0
Log Po/w (XLOGP3) : -1.33
Log Po/w (WLOGP) : -2.08
Log Po/w (MLOGP) : -1.99
Log Po/w (SILICOS-IT) : -2.25
Consensus Log Po/w : -1.53

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -0.85
Solubility : 39.4 mg/ml ; 0.141 mol/l
Class : Very soluble
Log S (Ali) : -0.92
Solubility : 33.7 mg/ml ; 0.121 mol/l
Class : Very soluble
Log S (SILICOS-IT) : 1.01
Solubility : 2860.0 mg/ml ; 10.2 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 3.9

Safety of [ 69-74-9 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338-P310 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 69-74-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 69-74-9 ]
  • Downstream synthetic route of [ 69-74-9 ]

[ 69-74-9 ] Synthesis Path-Upstream   1~1

  • 1
  • [ 147-94-4 ]
  • [ 69-74-9 ]
YieldReaction ConditionsOperation in experiment
96% With hydrogenchloride In methanol at 2 - 25℃; for 4 h; An oven- dried 250 mL round bottom flask equipped with a magnetic stir bar was charged with 3.35 g of cytarabine-HCl and 6.0 mL of DMPU. Into this flask the reaction mixture from example 12 was filtered directly and the DABCO-HCl salt was washed quickly with acetonitrile (1.x.15 mL). Volatiles were removed on a rotary-evaporator under aspirator vacuum (bath temp <35° C.). The residual oil was briefly kept under high vacuum and stirred at room temperature for 48 h. The reaction mixture was treated with 100 mL of MeOH and stirred for 2 hours at room temperature. The pH of the reaction mixture was adjusted to 7.0 using 25 wt percent NaOMe solution in methanol (approximately 13 mL were required). At this stage the reaction mixture was turbid. HPLC was run to insure integrity of the reaction profile. The reaction mixture was evaporated to dryness and the residue was stirred with 50 mL of dichloromethane for 30 minutes at room temperature. The precipitate was collected by filtration, washed with methylene chloride (1.x.20 mL) and transferred back to the flask, stirred again with 50 mL of dichloromethane for 15 minutes and filtered. The solid was stirred with 200 mL of ethanol for 1-2 hours, filtered and washed with ethanol (2.x.10 mL). The filtrate was evaporated to dryness to give 4.90 g of a white solid. This solid was dissolved in 10 mL of H2O and stirred at room temperature overnight to give a solid which was collected by filtration, washed with water (2.x.3 mL) and dried in a vacuum oven to give compound 9, 1.38 g, (26percent).
Reference: [1] Patent: US2004/92476, 2004, A1, . Location in patent: Page/Page column 22
[2] Patent: WO2005/25552, 2005, A2, . Location in patent: Page/Page column 20-21
Same Skeleton Products
Historical Records